ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years
Yunhua Liu
Matched on ORCID iD 0000-0002-2631-795X; OpenAlex author ID A5101562905. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 21
2024: 2 papers · 2025: 2 papers · 2026: 2 papers
Papers 6
- Targeting DGAT1 reprograms lipid landscape and restores CD8⁺ T cell immunity in pancreatic cancer. Last author DOI 10.1038/s41467-026-74315-2↗
- MTFP1 drives pancreatic cancer liver metastatic colonisation by regulating mitochondrial metabolism reprogramming. Co-author DOI 10.1136/gutjnl-2025-336323↗
- A novel oncolytic poxvirus carrying CD47 nanomabs in the treatment of pancreatic cancer by reshaping the immune microenvironment. Co-author DOI 10.1016/j.canlet.2025.217934↗
- The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-1712↗
- IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling. Co-author DOI 10.1016/j.celrep.2024.114088↗
- Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer. Last author DOI 10.1158/2159-8290.cd-23-0584↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qi Zhang · 2 shared papers, 2026 · strength 0.49
- Zhongkun Liu · 2 shared papers, 2024–2026 · strength 0.43
- Tingbo Liang · 2 shared papers, 2024–2026 · strength 0.42
- Paper MTFP1 drives pancreatic cancer liver metastatic colonisation by regulating mitochondrial metabolism reprogramming. DOI 10.1136/gutjnl-2025-336323↗
- Paper IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by E… DOI 10.1016/j.celrep.2024.114088↗
- Hong Jiang · 2 shared papers, 2024–2025 · strength 0.38
- Yang Chen · 1 shared paper, 2026 · strength 0.24
- Yiting Xu · 1 shared paper, 2026 · strength 0.24
- Zheling Chen · 1 shared paper, 2025 · strength 0.23
- Liu Yang · 1 shared paper, 2025 · strength 0.23
- Wenyan Xie · 1 shared paper, 2025 · strength 0.20
- Jie Yang · 1 shared paper, 2025 · strength 0.20
- Hubing Shi · 1 shared paper, 2025 · strength 0.20
- Yuan Wang · 1 shared paper, 2025 · strength 0.20
- Nengwen Ke · 1 shared paper, 2025 · strength 0.20
- Xiaobao Wei · 1 shared paper, 2024 · strength 0.18
- Jiangchao Wu · 1 shared paper, 2024 · strength 0.18
- Junli Wang · 1 shared paper, 2024 · strength 0.18
- Yi Duan · 1 shared paper, 2024 · strength 0.18
- Chenlei Zheng · 1 shared paper, 2024 · strength 0.18
- Mao Ye · 1 shared paper, 2024 · strength 0.18
- Bo Kong · 1 shared paper, 2024 · strength 0.18
- Wenhua Sang · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.